Replies to post #502082 on NorthWest Biotherapeutics Inc (NWBO)

[HyGro]

The 10K captures all events and financials not in the 10Q that was filed three months earlier.

There is other evidence that the SAP was filed AFTER the unblinding. The original protocol had NO recurrent GBM arm, it was only for naïve GBM patients. The rGBM arm could not have been considered until they had unblinded data as they had no knowledge of the sample was placebo controlled until they had unblinded the dataset. They wouldn't have known if they had adequate sample size to even consider using it as an analytics arm.